Patent details

Basic Information

Publication number:

EP2373681

PCT Application Number:

PCT/US/2009/067469

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP098325228

PCT Publication Number:

WO/2010/068735

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS OF ALBIGLUTIDE

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES D'ALBIGLUTIDE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND ALBIGLUTIDE

SPC Number:

Dates

Filing date:

10/12/2009

Grant date:

18/01/2017

EP Publication Date:

18/01/2017

PCT Publication Date:

17/06/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/10/2011

EP B1 Publication Date:

18/01/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/12/2023

Expiration date:

10/12/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/01/2018

 

 

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

History of Owners

From:

01/09/2017

To:

10/01/2018

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

From:

10/12/2009

To:

01/09/2017

Name:

GlaxoSmithKline LLC

Address:

Corporation Service Company 2711 Centerville Road Suite 40, Wilmington DE 19808, United States (US)

Agent

Name:

KIRKPATRICK

From:

28/02/2017

Address:

AVENUE WOLFERS 32, 1310, LA HULPE, Belgium (BE)

To:

Inventor

1

Name:

STEWART Murray, W.

Address:

United States (US)

2

Name:

BUSH Mark, A.

Address:

United States (US)

3

Name:

YANG Yonghong

Address:

United States (US)

Priority

1

Priority Number:

121229 P

Priority Date:

10/12/2008

Priority Country:

United States (US)

2

Priority Number:

150909 P

Priority Date:

09/02/2009

Priority Country:

United States (US)

3

Priority Number:

163995 P

Priority Date:

27/03/2009

Priority Country:

United States (US)

4

Priority Number:

238723 P

Priority Date:

01/09/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 14/605;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2018/03

Publication date:

20/02/2018

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

201740

Publication date:

04/10/2017

Description:

Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20180000011A

Date Registered:

10/01/2018

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Changements de noms et d'adresses

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

GlaxoSmithKline LLC

Address:

251 Little Falls Drive, Wilmington, DE 19808, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

22/11/2022

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
10/01/2018	Request For Change	4
11/01/2018	Outgoing Correspondence	1
28/02/2017	Power Of Attorney	1